» Articles » PMID: 16799888

Visceral Fat Accumulation and Insulin Resistance Are Important Factors in Nonalcoholic Fatty Liver Disease

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 2006 Jun 27
PMID 16799888
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nonalcoholic fatty liver diseases are often associated with obesity, insulin resistance, and excessive visceral fat accumulation. The aims of this study were (1) to evaluate the relationship between the severity of fatty liver and visceral fat accumulation in nonalcoholic fatty liver diseases, and (2) to investigate the relationships of fatty liver with biochemical data and insulin resistance.

Methods: One hundred twenty-nine subjects (63 women) with fatty liver diagnosed by ultrasonography were enrolled. Subjects positive for hepatitis B virus, hepatitis C virus, or autoimmune antibodies and those whose alcohol intake was over 20 g/day were excluded. The visceral fat area at the umbilical level and the liver-spleen ratio were evaluated by computed tomography.

Results: The severity of fatty liver evaluated by ultrasonography showed a significant positive relationship with the visceral fat area and waist circumstance (fatty liver severity: mild, 92.0 +/- 30.9 cm(2); moderate, 122.1 +/- 32.6 cm(2); severe, 161.0 +/- 48.4 cm(2); P < 0.0001). The visceral fat area and liver-spleen ratio were negatively correlated (r = -0.605, P < 0.0001). The severity of fatty liver showed strong positive relationships with serum aspartate aminotransferase, alanine aminotransferase, fasting plasma glucose, fasting plasma insulin, and insulin resistance. The severity of fatty liver was positively related to the visceral fat area in 49 nonobese subjects (body mass index <25).

Conclusions: The severity of fatty liver was positively correlated with visceral fat accumulation and insulin resistance in both obese and nonobese subjects, suggesting that hepatic fat infiltration in nonalcoholic fatty liver disease may be influenced by visceral fat accumulation regardless of body mass index.

Citing Articles

Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey.

Wang Y, Fu C, Jin H, Yang Y, Li X, Liu K Front Endocrinol (Lausanne). 2025; 15:1468228.

PMID: 39897962 PMC: 11781989. DOI: 10.3389/fendo.2024.1468228.


Association of gene Pro512Ala polymorphism with nonalcoholic fatty liver disease.

Asadi A, Rostami M, Shafiee R, Ardalani A, Dehghanitafti A, Golshadi Z Arch Endocrinol Metab. 2024; 68:e230216.

PMID: 39420901 PMC: 11460970. DOI: 10.20945/2359-4292-2023-0216.


Multi-dimensional comparison of abdominal obesity indices and insulin resistance indicators for assessing NAFLD.

Shi J, Chen J, Zhang Z, Qian G BMC Public Health. 2024; 24(1):2161.

PMID: 39123158 PMC: 11311916. DOI: 10.1186/s12889-024-19657-6.


Application of intelligent tongue image analysis in Conjunction with microbiomes in the diagnosis of MAFLD.

Dai S, Guo X, Liu S, Tu L, Hu X, Cui J Heliyon. 2024; 10(7):e29269.

PMID: 38617943 PMC: 11015139. DOI: 10.1016/j.heliyon.2024.e29269.


Correlation between computed tomography-based body composition parameters and hepatic venous pressure gradient in patients with cirrhosis: a systematic review and meta-analysis.

Yang S, Zhang Z, Chen Q, Hu Y, Su T, Sun X Diagn Interv Radiol. 2024; 30(6):385-401.

PMID: 38293897 PMC: 11589527. DOI: 10.4274/dir.2023.232553.


References
1.
Trayhurn P, Wood I . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92(3):347-55. DOI: 10.1079/bjn20041213. View

2.
Hui J, Hodge A, Farrell G, Kench J, Kriketos A, George J . Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology. 2004; 40(1):46-54. DOI: 10.1002/hep.20280. View

3.
Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

4.
Rinella M, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M . Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl. 2001; 7(5):409-14. DOI: 10.1053/jlts.2001.23787. View

5.
Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I . Liver fibrosis in overweight patients. Gastroenterology. 2000; 118(6):1117-23. DOI: 10.1016/s0016-5085(00)70364-7. View